Femme et Homme
- | Pays :
- United Kingdom
- Spain
- France
- Les 8 autres...
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to compare the efficacy of dasatinib with that of high-dose (800-mg) imatinib in participants with chronic phase chronic myeloid leukemia who achieved only a suboptimal response after at least 3 months of monotherapy with 400-mg imatinib. The safety of these treatments will also be evaluated.
Critère d'inclusion
- Leukemia, Myeloid, Chronic